HIF1A and central nervous system cancer: Induction of HIF-1α and its target BNIP3 was also detectable in LNT-229 glioma cells (Figure S3D) as well as in LIM1215 and SW948 cells in the presence of cetuximab and bevacizumab in hypoxia (Figure S3E).